**Core Concept**
Acute Myocardial Infarction (AMI) management involves pharmacological interventions to restore blood flow, reduce infarct size, and alleviate symptoms. This includes antiplatelet agents, anticoagulants, thrombolytics, beta-blockers, and nitrates.

**Why the Correct Answer is Right**
The management of AMI primarily focuses on restoring blood flow to the ischemic myocardium. Antiplatelet agents like aspirin and P2Y12 inhibitors (e.g., clopidogrel) are used to prevent platelet aggregation. Anticoagulants like heparin and low molecular weight heparins (LMWHs) are used to prevent clot extension and propagation. Thrombolytics like streptokinase and tissue plasminogen activators (tPA) are used to dissolve the occluding thrombus. Beta-blockers reduce myocardial oxygen demand by decreasing heart rate and contractility, while nitrates dilate coronary arteries and reduce preload.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it is not typically used in the management of AMI.
**Option B:** This option is incorrect as it is not a primary treatment for AMI.
**Option C:** This option is incorrect as it is not commonly used for AMI management.

**Clinical Pearl / High-Yield Fact**
In the management of AMI, timely administration of thrombolytics is crucial to restore blood flow and reduce infarct size. However, thrombolytics should be used with caution in patients with a history of bleeding disorders or recent surgery.

**Correct Answer: D.**